Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease
机构：[1]Department of Endocrinology and Metabolism, Zhongshan Hospital, FudanUniversity, Shanghai, China[2]Fudan Institute for Metabolic Disease, FudanUniversity, Shanghai, China[3]Department of Gastroenterology, Zhongshan Hospital, Fudan University, Shanghai, China[4]Department of Endocrinologyand Metabolism, The First Affiliated Hospital of Kunming Medical University,Kunming, China内科科室内分泌科昆明医科大学附属第一医院[5]Department of Radiology, Zhongshan Hospital, FudanUniversity, Shanghai, China[6]Department of Pathology, Shanghai MedicalCollege, Fudan University, Shanghai, China[7]Department of Endocrinologyand Metabolism, Wusong Branch of Zhongshan Hospital, Fudan University,Shanghai, China
Background The performance of liver stiffness measurements (LSMs) obtained using FibroScan can be affected by several factors, and cut-off values are different for fibrosis caused by various aetiologies. The study aims to evaluate the diagnostic accuracy of LSM in nonalcoholic fatty liver disease (NAFLD) patients with abnormal glucose metabolism and investigate whether the LSM value would be affected by metabolic indicators. Methods The study involved 91 NAFLD patients with abnormal glucose metabolism who underwent liver biopsy. The diagnostic accuracy of LSM value was evaluated by the receiver operator characteristic (ROC) curves, with the biopsy results taken as the gold standard. Multivariate linear regression and subgroup analysis were performed to determine the correlated indicators. Results The areas under the ROC curves (AUROCs) of LSM values for detecting fibrosis stage >= 1, 2, 3 and 4 were 0.793 (95% confidence interval [CI]: 0.695-0.871), 0.764 (95% CI: 0.663-0.846), 0.837 (95% CI: 0.744-0.906) and 0.902 (95% CI: 0.822-0.955), with cut-off values of 6.3, 7.6, 8.3 and 13.8 kPa, respectively. Multivariate linear regression demonstrated that haemoglobin A1c (HbA1c, beta = 0.205, P = 0.026) and alanine aminotransferase (ALT, beta = 0.192, P = 0.047) were independently associated with the LSM value after adjustment for fibrosis stage, ballooning and inflammation grade from liver biopsy. Subgroup analysis demonstrated that LSM values were slightly higher in patients with HbA1c >= 7% than in those with HbA1c < 7% and in patients with body mass index (BMI) >= 30 kg/m(2) than in those with BMI < 30 kg/m(2). Conclusions FibroScan was valuable for the evaluation of liver fibrosis in NAFLD patients with abnormal glucose metabolism. FibroScan is recommended to evaluate severe fibrosis, especially to exclude advanced fibrosis. Glucose metabolism state may affect LSM values.
基金：
Shanghai Municipal Population and Family Planning Commission [201740092]; Shanghai TCM Development Office [ZY (2018-2020)-FWTX3019]; Foundation of Fudan University, China [20520133483]; Science and Technology Commission of Shanghai MunicipalityScience & Technology Commission of Shanghai Municipality (STCSM) [20ZR1410200]; Xiamen Municipal Bureau of Science and Technology [3502Z20209043]; Special Project of Integrating Traditional Chinese and Western Medicine in Shanghai General Hospital from the Shanghai Municipal Population and Family Planning Commission
第一作者机构：[1]Department of Endocrinology and Metabolism, Zhongshan Hospital, FudanUniversity, Shanghai, China[2]Fudan Institute for Metabolic Disease, FudanUniversity, Shanghai, China
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Xinyu Yang,Xinxia Chang,Shengdi Wu,et al.Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease[J].LIPIDS IN HEALTH AND DISEASE.2021,20(1):doi:10.1186/s12944-021-01453-5.
APA：
Xinyu Yang,Xinxia Chang,Shengdi Wu,Xiaoyang Sun,Xiaopeng Zhu...&Xin Gao.(2021).Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease.LIPIDS IN HEALTH AND DISEASE,20,(1)
MLA：
Xinyu Yang,et al."Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease".LIPIDS IN HEALTH AND DISEASE 20..1(2021)
